Cargando…
Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
For over a century, a complex relationship between schizophrenia diagnosis and development of many cancers has been observed. Findings from epidemiological studies are mixed, with reports of increased, reduced, or no difference in cancer incidence in schizophrenia patients. However, as risk factors...
Autores principales: | Hamoud, Abdul-Rizaq, Bach, Karen, Kakrecha, Ojal, Henkel, Nicholas, Wu, Xiaojun, McCullumsmith, Robert E., O’Donovan, Sinead M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570456/ https://www.ncbi.nlm.nih.gov/pubmed/36233136 http://dx.doi.org/10.3390/ijms231911835 |
Ejemplares similares
-
Altered purinergic receptor expression in the frontal cortex in schizophrenia
por: Alnafisah, Rawan, et al.
Publicado: (2022) -
Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets
por: Zhang, Xiaolu, et al.
Publicado: (2022) -
Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2018) -
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
por: Imami, Ali S., et al.
Publicado: (2021) -
The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
por: O’Donovan, Sinead M., et al.
Publicado: (2017)